Editas Medicine, Inc.
EDIT· Nasdaq
EDITEditas Medicine, Inc.
Filed May 13, 2016 · 10-Q · 43 days after period end · 0001558370-16-005983
| Metric | Q1 2016 | Q1 2015 |
|---|---|---|
| Net Income | -$17.75M | -$5.29M |
| EPS Diluted | -$0.80 | -$2.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Editas Medicine, Inc. · CIK 1650664 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 13, 2016 · 43 d after period end
